Our Sponsors
Website https://virtueinsight.com/events/pharma-regulatory-summit-2026-2/ |
Edit Freely
Category pharma
Deadline: March 23, 2026 | Date: March 24, 2026
Venue/Country: Mumbai, India
Updated: 2026-01-21 15:18:40 (GMT+9)
virtueinsight.co.in or M: +91 9361957193DELEGATE REGISTRATION :Super Early Bird Price (Valid until 06th Feb 2026) – INR 10,000+ GST (18%) per delegateEarly Bird Price (Valid from 07th Feb - 13th March 2026) – INR 12,000+ GST (18%) per delegateStandard Price – INR 15,000 + GST (18%) per delegateSPONSORS:Conference Sponsor – Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) / paid Speaker Slot / create brand awareness, you can simply email or call your interest and queries.KEY SPEAKERS:MAYUR PARMAR, Drugs Inspector (Deputy Collector, Gujarat Government), FDANAGENDRAN IRUKULAPATI, Sr. Vice President – Global Regulatory Affairs, Aurobindo PharmaRAMANARAYANA PARHI, Vice President & CIO, Alkem LaboratoriesJULIET REBELLO, Director - Clinical Dev Strategy & Medical Writing,CiplaANJU AGARWAL, Director Global Patient Safety, Advanz PharmaAMITA BHAVE, Director Regulatory Affairs, AstraZenecaMILIND ANTANI, Leader, Pharma and Healthcare, Nishith Desai AssociatesPALLAVI TRIVEDI, Associate Director – Diabeties and Obesity, Global Business Services (GBS), Novo Nordisk SANTOSH TAUR, Director Medical Affairs, Vaccines, Rare Diseases and Digital, PfizerAKSHAYA ODAK, Head Regulatory Affairs (Biotech), LupinPROTITI BAGCHI, Associate Director- Digital Transformation, GSKSUCHITA MORE, Director Medical Modernization, Asia Pacific & Japan, Merck Sharp & Dohme AMARNATH SUGUMARAN, Director - Medical Affairs, Cipla SHUVANKAR BALLAV, Head, Regulatory Affairs - Advanced Biotech Lab (ABL), Ipca LaboratoriesPANKAJ CHAUDHARI, Head - Global Regulatory Affairs (Biosimilar), AbbottAMOL CHOULWAR, Group Leader - Regulatory Affairs (Biosimilar Peptides New Drugs Vaccines),Cipla MINOO BIJU, Head-Regulatory Affairs, Piramal Pharma SolutionsMARTINA GOMES, Head, Reg Affairs – CH, BayerPRIYA CHATTERJEE, Head Regulatory Affairs - South Asia, BayerSHIRAZ KANDAWALLA, Head – Regulatory, Quality & Safety – India, Ferring PharmaSADANAND KULKARNI, Head - Medical, Regulatory, Vigilance & Quality (South Asia), Fresenius KabiJAYASHRI PRAMOD, Regulatory Principal Specialist, Novo NordiskSUSHMITA KUSWA, Head Medical & Regulatory Affairs, PiramalOMPRAKASH S. SADHWANI, Former Joint Commissioner & Controlling Authority, FDA (Maharashtra State)RUCHIR SHAH, Head Medical Devices Category, Regulatory & Safety Manager, Reckitt BenckiserRASHMI HEGDE, Former Executive Vice President – Medical, GSKNEELU GOEL, Regulatory Affairs - Head Business Continuity & Compliance, Sun PharmaPRIYA PRASAD, General Manager – PV, LupinKAVITA LAMROR, Partner, RWE & Digital Transformation, Maxis Clinical SciencesPlus more joining soonFOCUS AREAS:• Digital Transformation• Biologics & Biosimilars • Regulatory Writing & Submissions • Clinical Trials/DCT • Patient Safety • RWE/RWD • New Drugs • Generic Groups• Vendor Management• Medical DevicesWHO SHOULD ATTEND AND WHO YOU’LL MEET:This conference is specifically designed for pharma, biotech, CRO’s, Government and Regulators, Hospitals/Trial Sites, Technology / Solution Providers from following areas;Regulatory Affairs, Clinical Trials / Clinical Data, Biologics & Biosimilars, Medical Devices, Regulatory Writing/Medical Writing/Publishing/Information/Submissions, Document and eRecords Management, Clinical Trials Management/Data, Outsourcing /Vendor Management, Quality Assurance/Quality Control, Technology AI, ML, Blockchain, Big Data, Supply Chain Management , Government- Department of Health, Vaccines R&D / Innovation, ConsultantsGet more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, and meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies at the high-level conference.Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.